#154: How Pharmacovigilance Keeps MS Therapies Safe: From Drug Development to Real-World Monitoring (with Dr. Nora Möhn)
Multiple sclerosis treatments have advanced fast—but safety monitoring matters more than ever. In this interview, Dr. Nora Möhn explains pharmacovigilance step by step: from clinical trial phases and approval to post-marketing surveillance and reporting systems (EU/US/UK/Canada). You’ll learn how neurologists weigh benefits and risks, and how you can discuss side effects confidently.
#121: MS, TheMay50K, and mental strength – a conversation with Susanne Melanie Schmid
In this interview, Susanne Melanie Schmid shares her journey with multiple sclerosis, how she found strength in vulnerability, and what helped her push beyond limits—literally and figuratively. As part of the international TheMay50K challenge, she not only walked over 60 kilometers, but also built meaningful connections, including with MS advocates in South Africa. Susanne speaks […]
#116: Sugar and health. Why a sugar-reduced diet makes sense with Dr. Franz-Werner Dippel
Dr. Dippel gives a summary of the cause and effect of increased sugar consumption on health and why less sugar is good.
#110: 10 things you should know about MRI scans for MS with neuroradiologist Prof. Mike Wattjes
Prof. Mike Wattjes ist Neuroradiologe an der Medizin. Hochschule Hannover und erklärt gut verständlich, was Du zur MRT bei MS wissen solltest.
#106: Trigeminal neuralgia and MS – an invisible challenge. Interview with Dr. Monika Köchling
MS patients can also suffer from trigeminal neuralgia, which is very painful. Dr. Köchling explains the treatment. Translated interview.
#066: Pioneering Paths. Empowering Young Minds in MS & NMO Research with Dr. Sara Samadzadeh
Dr. Sara Samadzadeh contributes to research in the field of NMOSD and MS by creating networks between young researchers worldwide.
#001: My personal journey with MS
Before I’m going to ask other people living with MS about their way I’m sharing my personal journey with the disease so far.
